Olmesartan Medoxomil

CAS Number: 144689-63-4

Molecular Formula: C29H30N6O6

Purity: Olmesartan Medoxomil 98% purity

About Olmesartan Medoxomil

Olmesartan Medoxomil (CAS 144689-63-4) serves as a cornerstone in the global antihypertensive market, where it is extensively utilized as a high-potency API for the formulation of advanced ARB medications and fixed-dose combinations with calcium channel blockers. (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropa...

Variants

OLMESARTAN

CAS: 144689-63-4

Synonyms

5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346
Benicar
CS 866
CS-866
CS866

View all

Olmesartan Medoxomil Specifications

CAS Number

144689-63-4

Molecular Formula

C29H30N6O6

Molecular Weight

558.59 g/mol

IUPAC Name

(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate

Canonical SMILES

CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O

InChI Key

UQGKUQLKSCSZGY-UHFFFAOYSA-N

InChI

InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)

HSN No

29349990

CAS Number

144689-63-4

Molecular Formula

C29H30N6O6

Molecular Weight

558.59 g/mol

IUPAC Name

(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate

Canonical SMILES

CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O

InChI Key

UQGKUQLKSCSZGY-UHFFFAOYSA-N

InChI

InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)

HSN No

29349990

Molecular Weight

558.59 g/mol

Purity

Olmesartan Medoxomil 98% purity

Antihypertensive Agent

A selective angiotensin II receptor antagonist used as a primary treatment for essential hypertension to lower blood pressure and reduce the risk of cardiovascular events such as stroke and myocardial infarction

Pharmaceutical Active Ingredient

A nonpeptide benzimidazole derivative utilized in the formulation of oral medications to manage high blood pressure in adults and pediatric patients

Renoprotective Agent

A therapeutic compound employed to slow the progression of diabetic nephropathy and chronic kidney disease by inhibiting the renin-angiotensin-aldosterone system

Cardiovascular Research Tool

A high-affinity AT1 receptor blocker used in clinical and pharmacological studies to investigate vascular remodeling, arterial stiffness, and the role of ACE2 in heart failure management.

5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346
Benicar
CS 866
CS-866
CS866